Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)
6.55
+0.08 (1.24%)
At close: Jan 23, 2026
SHA:603718 Market Cap
SHA:603718 has a market cap or net worth of 4.27 billion as of January 23, 2026. Its market cap has decreased by -7.81% in one year.
Market Cap
4.27B
Enterprise Value
3.98B
Revenue
246.35M
Ranking
n/a
PE Ratio
24.69
Stock Price
6.55
Market Cap Chart
Since May 15, 2015, SHA:603718's market cap has increased from 2.75B to 4.27B, an increase of 55.45%. That is a compound annual growth rate of 4.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 4.22B | 5.46% |
| Dec 31, 2025 | 4.00B | -12.02% |
| Dec 31, 2024 | 4.55B | -35.48% |
| Dec 29, 2023 | 7.05B | 11.42% |
| Dec 30, 2022 | 6.32B | -35.82% |
| Dec 31, 2021 | 9.85B | 21.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pulike Biological Engineering | 4.71B |
| Innovita Biological Technology | 4.70B |
| Beijing Kawin Technology Share-Holding | 4.39B |
| Guanhao Biotech | 4.33B |
| Zhejiang Shouxiangu Pharmaceutical | 4.25B |
| Shanghai Shen Lian Biomedical | 4.18B |
| Boji Medical Technology | 4.13B |
| Shenzhen Bioeasy Biotechnology | 4.09B |